* ToxicoGenomics, 209 Silver Creek Tr., Chapel Hill, North Carolina 27514, and Cubist Pharmaceuticals, 65 Hayden Ave., Lexington, Massachusetts 02421
1 To whom correspondence should be addressed. Fax: (919) 408-0365. E-mail: ccorton{at}msn.com.
Received June 3, 2004; accepted September 15, 2004
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() |
---|
Key Words: phthalate ester; PPAR; testis; peroxisome proliferator; male reproductive tract.
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() |
---|
Many of the adaptive consequences of PP exposure are mediated by a subset of nuclear receptor superfamily members called peroxisome proliferator-activated receptors (PPARs). The PPAR family includes three distinct subtypes, PPAR, PPARß (also known as NUC1 or PPAR
), and PPAR
encoded by separate genes (Lemberger et al., 1996
). PP activate PPARs leading to altered expression of genes with roles in metabolism, cell growth, and stress responses (Corton et al., 2000
). Most, if not all responses to PP including some phthalates in the liver are dependant on PPAR
(Klaunig et al., 2003
). Given recent findings describing novel aspects of phthalate-PPAR interactions, we review here evidence supporting or discounting roles for PPARs in mediating the toxic effects of phthalates on the male reproductive tract.
Effects of Phthalates on the Developing Male Reproductive Tract in Utero
Exposure of male rats to some diester and monoester phthalates in utero results in profound changes in the testis and other androgen-dependent structures. The extent and severity of the changes depend in large part on the timing and duration of the exposure and how the compound is administered. Studies in which reproductive tract defects have been observed involve exposure of pregnant dams during the time of androgen-dependent sexual differentiation, estimated to begin in the rat gestation day 12 (GD 12). Studies in which di-n-butyl phthalate (DBP) or butylbenzyl phthalate (BBP) were dosed before GD 12 had no effect on reproductive tract development, as expected, but did produce other malformations (Ema et al., 2000
; Ema and Miyawaki, 2002
). Exposure regimens that resulted in the most consistent and robust effects involved administration of the phthalate by daily gavage throughout development of the reproductive tract until birth or shortly thereafter (Gray et al., 2000
; Mylchreest et al., 1999
). A number of studies showed common defects in the male rat reproductive tract after in utero exposure to DBP (Barlow and Foster, 2003
; Barlow et al., 2004
; Fisher et al., 2003
; Mylchreest et al., 1999
, 2000
, 2002
; Wine et al., 1997
), di-(2-ethylhexyl) phthalate (DEHP) (Moore et al., 2001
; Parks et al., 2000
), and BBP (Nagao et al., 2000
; Piersma et al., 2000
; Tyl et al., 2004
). These effects included those in the testis as well as other organs that depend on testosterone for proper development (Table 1). Some effects caused by DBP were found to be permanent including gross lesions in the testis, vasa deferentia, seminal vesicles, prostate, and penis, as well as decreases in anogenital distance and nipple retention (Barlow et al., 2004
). In addition, DBP at 1% in the diet (Wine et al., 1997
) and BBP at 750 mg/kg/day (Tyl et al., 2004
) but not 500 mg/kg/day (Nagao et al., 2000
) decreased total number of sperm and indices for mating, fertility, and pregnancy in F1 generation rats in multi-generation exposure studies. In contrast, di-isononyl phthalate (DINP) was a weak reproductive toxicant as in utero exposure led only to increased nipple retention (Gray et al., 2000
). Dimethyl phthalate and diethyl phthalate had no adverse effects on the development of the male reproductive tract (Gray et al., 2000
). Monobutyl phthalate (MBP), the principle metabolite of DBP, disrupted the descent of the fetal testis (Imajima et al., 2001
; Shono and Suita, 2003
).
|
The effects of the active phthalates on the male rat reproductive tract share similarities with a condition in humans termed testicular dysgenesis syndrome (TDS). As proposed by Skakkebaek et al. (2001), TDS includes testicular germ cell cancers, poor semen quality, crytorchidism and hypospadias, all thought to arise from disruption of embryonic gonadal development. That TDS is increasing in developing countries and that environmental exposure to man-made male reproductive toxicants are responsible for TDS is unresolved, partly because of the lack of high quality data allowing comparison of studies (Sharpe, 2001
). Only increases in testicular cancer over the last 5090 years have been established (Bergstrom et al., 1996
; Toppari et al., 1996
). TDS, like exposure to phthalates is associated with abnormal function in both Leydig and Sertoli cells, resulting in downstream consequences in the testis and sex organs (Fig. 1). Exposure of rats to DBP in utero increased the proportion of immature Sertoli cells unable to support spermatogenesis and the number of multinucleated gonocytes, possibly through alterations in Sertoli cell-gonocyte interactions (Fisher et al., 2003
). How DBP treatment interferes with these interactions and in particular, gonocyte cytokinesis is not understood.
|
Alteration of Testis Structure and Function by Phthalates in Postnatal and Adult Rats
Exposure of postnatal, preadolescent, and adult rats to some phthalates produces a different set of sequelae in testis compared to that of male rats exposed in utero. The age of the rat at the time of exposure has a dramatic effect on the testis as younger animals are more sensitive to the effects of phthalates (Gray and Gangolli, 1986). Compared to rats, mice are relatively resistant at any age. Some phthalates induce testicular toxicity in guinea pigs (Gray et al., 1982
) and ferrets (Lake et al., 1976
). Resistance to phthalate toxicity in Syrian hamsters is likely due to inefficient metabolic activation of diesters to monoesters by gut esterases compared to that in rats (Gray et al., 1982
). Exposure to phthalates in responsive species leads to decreases in seminiferous tubule diameter and testis weight. At least in rats, this occurs through increased germ cell apoptosis and necrosis preceding the sloughing of germ cells into the tubular lumen (Gangolli, 1982
).
The primary cellular target of toxic phthalates is the Sertoli cell which exhibits biochemical and morphological changes after exposure. FSH-stimulated cAMP accumulation in primary Sertoli cells was inhibited by Mon-(2-ethyl)-hexlphthalate (Heindel and Chapin, 1989; Lloyd and Foster, 1988
), MBP and monopentyl phthalate, but not monomethyl or monoethyl phthalate (Heindel and Powell, 1992
). Decreases in proliferation of Sertoli cells were observed after DEHP exposure in vivo (Li et al., 2000
) or after exposure to MEHP in vitro (Li et al., 1998
; Li and Kim, 2003
), and may occur through a block in FSH-stimulated Sertoli cell proliferation (Li et al., 1998
). Two genes which play roles in Sertoli cell proliferation and differentiation, Müllerian inhibiting substance and GATA-4, were decreased by MEHP in Sertoli cells within cultured testis from GD 18 and PND 3 rats (Li and Kim, 2003
). Sertoli cell numbers recover somewhat during the course of exposure, as the decreases observed at one week were no longer evident after two to three weeks exposure to DEHP (Dostal et al., 1988
). In rats exposed to MEHP, collapse in the Sertoli cell intermediate filament vimentin structure (indicative of changes in cell morphology) was observed as early as 3 h, followed by increases in perinuclear condensation of vimentin at 612 h. These changes preceded or were coincident with increased apoptosis in germ cells (Richburg and Boekelheide, 1996
). Immunostaining for flamingo1/Celsr2, a G protein coupled receptor family member that may link cell-cell adhesion to G-protein dependent signaling was redistributed within 2 h of MEHP exposure and disappeared by 12 h, indicating that this protein is a proximate target of MEHP (Richburg et al., 2002
).
Germ cells exhibit changes that may be secondary to effects on Sertoli cells. In the intact testis DEHP increased the generation of reactive oxygen species with concomitant decreases in the concentration of glutathione and ascorbic acid, and in primary cultures, oxidative stress was selectively induced in germ cells but not in Sertoli cells treated with MEHP (Kasahara et al., 2002). MEHP may specifically target the stages IXXI of the mouse seminiferous cycle as apoptosis was increased in cells of these timed tubule segments treated in vitro (Suominen et al., 2003
). Sertoli cells from mice treated with DEHP express the Fas ligand (FasL) while associated spermatocytes express Fas, the receptor for FasL, indicating that activation of the Fas system originating in Sertoli cells could lead to subsequent apoptosis in spermatocytes (Ichimura et al., 2003
). Experiments in gld mice which carry a defective FasL gene revealed that germ cell apoptosis after MEHP exposure had both Fas-dependent (Richburg et al., 2000
) and Fas-independent components (Giammona et al., 2002
). Additionally, MEHP alters the expression and activity of death receptors 4,5,6 in the testis which may act in concert with the Fas-signaling pathway to initiate germ cell apoptosis (Giammona et al., 2002
).
Leydig cells in postnatal and adult rats are also targeted by some active phthalates. DEHP (Jones et al., 1993; Kim et al., 2003
) and di-n-octyl phthalate (Jones et al., 1993
) decreased testosterone serum levels. Primary Leydig cells treated with MEHP or mono-octyl phthalate also exhibited decreases in testosterone secretion (Jones et al., 1993
) although the concentrations used to achieve these effects were very high (103 M). Human chorionic gonadotropin-induced testosterone secretion was suppressed by prior exposure of Leydig cells in culture to PP (Biegel et al., 1995
; Cook et al., 1992
; Liu et al., 1996
). No phthalates were tested in these studies, however. Decreases in testosterone levels may explain the decreased weights of accessory sex organs (seminal vesicle and prostate) in male rats exposed to DEHP that were partially reversed by co-administration of testosterone or gonadotropins (Gray and Gangolli, 1986
). Decreased testosterone levels may also play a role in the genesis of Leydig cell tumors (Klaunig et al., 2003
) through increases in compensatory Leydig cell proliferation observed with DEHP (Akingbemi et al., 2004
) and the PP, WY-14,643 (Biegel et al., 1992
). Two studies have shown increases in serum testosterone levels in male rats after exposure to DEHP at 200 mg/kg from PND 2148 (Akingbemi et al., 2001
) or relatively low doses of DEHP (10 or 100 mg/kg) for PND 2190 (Akingbemi et al., 2004
), which the authors attribute to an observed increase in Leydig cell numbers. Thus, short-term exposure to phthalates may lead to decreases in testosterone while longer exposures may stimulate Leydig cell proliferation resulting in consequent increases in testosterone. A more comprehensive time course would be useful to confirm these events for DEHP and other phthalates.
Expression of PPARs in the Testes
PPAR subtypes are expressed in the adult rat testes (Table 2). PPAR was expressed in Leydig and Sertoli cells of the adult rat (Braissant et al., 1996; Schultz et al., 1999
). Conflicting reports exist as to the expression of PPAR
in spermatocytes, with one report detecting expression (Schultz et al., 1999
) and the other negative for expression (Braissant et al., 1996). PPARß is expressed in Leydig and Sertoli cells but not in spermatocytes (Braissant et al., 1996). PPAR
, in contrast, is either weakly expressed or not expressed at all in these cell types (Braissant et al., 1996). The spectrum of PPAR subtype expression in rat Leydig cells is similar to that in a Leydig mouse cell line (MA-10); PPAR
and PPARß, but not PPAR
were expressed (Gazouli et al., 2002
). Although there are no reports, that we know of, that examine PPAR
target gene expression specifically in Sertoli cells or spermatocytes, there were increased levels of two PPAR
gene targets involved in peroxisomal ß-oxidation (acyl-CoA oxidase, multifunctional protein-1) in Leydig cells after adult rats were fed the PP ciprofibrate in the diet for two weeks (Nemali et al., 1988
) indicating that PPAR
expressed in Leydig cells is responsive to PP. In contrast, neither WY or the PP ammonium perfluorooctanoate increased peroxisomal ß-oxidation in Leydig cells from chronically treated rats (Biegel et al., 2001
).
|
Only expression of PPAR has been examined in the early postnatal testis (Schultz et al., 1999
). Expression of PPAR
was high in rat seminiferous tubules at PND 1 followed by a steady decline until PND 30 and an increase at PND 60. Information about expression of PPAR subtypes in the rat testis in utero is lacking but PPAR
-null (Lee et al., 1995
) and PPARß-null (Peters et al., 2000
) mice remain viable and fertile indicating that these receptors are not essential for mouse testicular development and fertility. Compensatory mechanisms have not been ruled out (e.g., increased expression of another PPAR subtype) that would allow proper testicular development.
PPAR was expressed in human Leydig cells and spermatocytes, but not in Sertoli cells (Schultz et al., 1999
). PPAR
and PPARß were expressed in human testis homogenates (Hase et al., 2002
). PPAR
may also be expressed although conflicting data exists (Elbrecht et al., 1996
; Hase et al., 2002
). Overall, these results indicate that PPAR subtypes are expressed in some types of adult cells in both rat and human testis. Further work is needed to determine if PPAR subtypes are expressed at both the transcript and protein levels in the testis throughout development from humans as well as a range of species susceptible to phthalate-induced testicular toxicity.
Activation of PPARs by Phthalate Esters
Despite their structural diversity compared to ligands that activate other nuclear receptors, PP do have similar structural requirements for activating PPARs in vitro and for initiating biological effects in animals. Most PP are amphipathic molecules containing a hydrophobic backbone (aliphatic or aromatic) linked to an acidic group or a moiety that can be metabolized to an acidic group. The acidic group is essential for ligand activity and typically consists of a carboxylic acid present in the parent compound. In the case of phthalates, esterases cleave a side chain from the diester resulting in a monoester containing a carboxylic acid. Some PP resemble endogenous lipid activators of PPARs such as long-chain saturated and unsaturated fatty acids (Xu et al., 1999).
Many phthalates activate PPARs in in vitro transactivation assays. In these assays either full length PPAR (Hurst and Waxman, 2003; Lampen et al., 2003
; Lapinskas et al., 2004
; Maloney and Waxman, 1999
) or hybrid transcription factors consisting of the PPAR ligand binding domain cloned to the glucocorticoid receptor (Lampen et al., 2003
) or GAL4 (Bility et al., 2004
) DNA binding domains were co-transfected into a mammalian cell line with a reporter gene (e.g., luciferase) under control of either PPAR binding sites called peroxisome proliferator responsive elements (PPREs) (Hurst and Waxman, 2003
; Lapinskas et al., 2004
; Maloney and Waxman, 1999
), glucocorticoid responsive elements (Lampen et al., 2003
) or the binding site for GAL4, UASG (Bility et al., 2004
). After time to express the receptor, the cells are treated with the phthalate esters. The reporter gene activity is then normalized to the activity of an additional reporter gene used as a transfection control and results are usually reported as a fold-change relative to a solvent control.
Mouse PPAR and PPAR
are activated by a large number of phthalate monoesters (Table 3). Monoester phthalates with longer aliphatic or aromatic side chains tended to be more potent activators. Monoesters with short straight chains either do not activate at all or activate weakly. Monooctyl phthalate possessing a longer side chain activated all three subtypes (Bility et al., 2004
), consistent with the observation that the longer the length of the fatty acid (up to 21 carbons), the better the fatty acid is at activating PPARs in vitro (Xu et al., 1999
). Monooctyl and monoheptyl phthalates are unique in that they can activate PPARs in vitro but do not act as PP because the aliphatic side chains are rapidly cleaved in vivo (Albro and Moore, 1974
). Steric restrictions appear to play a part in the ability of some monoesters to activate. Monoesters with the bulkiest side chains were less potent activators than MEHP or were completely inactive (e.g., mono-(1-methyl)-2-norbornyl phthalate, mono-(2,2-dimethyl-1-phenylpropyl) phthalate). The DEHP metabolite 2-ethylhexanoic acid weakly activated PPAR
and
compared to MEHP. In two studies the diesters DEHP and BBP were able to activate PPAR
and PPAR
, albeit weakly (Lampen et al., 2003
; Lapinskas et al., 2004
) despite the fact that the monoesters are considered to be the active toxic species. However, it is possible that the activation reflects a low level of esterase activity in the cell lines used.
|
Human PPARs were also activated by phthalates. All human PPAR subtypes were activated by MEHP, mono-(1-methyl)-heptyl phthalate and monobenzyl phthalate. Mono-sec-butyl phthalate, DL-mono-(1-methyl)-hexyl phthalate, mono-isoheptyl phthalate, mono-isodecyl phthalate, mono-isohexyl phthalate and mono-2-(methacryloyloxy)ethyl phthalate were more selective, activating only one or two of the subtypes. Importantly, the human PPARs required higher concentrations of the monoesters to be activated to the same levels as the corresponding mouse receptor (Bility et al., 2004; Hurst and Waxman, 2003
; Maloney and Waxman, 1999
).
Activation of PPARs comes about through two distinct mechanisms. Most PP are thought to bind directly to PPAR leading to activation. However, there is evidence that some PP may activate PPARs indirectly, through increasing the pool of endogenous activators, e.g., by displacing fatty acids from carrier proteins (Luebker et al., 2002). To determine whether phthalate esters interact directly with PPARs, the scintillation proximity assay (Nichols et al., 1998
) was used to assess the ability of phthalate esters to bind to human PPAR
and PPAR
(Lapinskas et al., 2004
). Some monoester phthalates interacted with both receptors, including, monohexyl phthalate, monooctyl phthalate, monobenzyl phthalate, but not shorter chain phthalates (monopropyl phthalate, monopentyl phthalate). Despite the short length of the side chain, monoethyl phthalate binds with low affinity to both PPAR
and PPAR
. BBP and DBP also bind weakly to both subtypes and this could explain why these diesters were able to weakly activate in transactivation assays. The data supports phthalate-induced changes in gene expression through binding to and activation of PPAR by monoester phthalates.
Activation of Other Nuclear Receptors by Phthalates
Phthalate esters have been tested for their ability to interact with sex hormone receptors. In transactivation assays, a wide range of diesters and monoesters did not act as androgen receptor agonists or antagonists in HepG2 cells (Gaido, personal communication). In addition, DEHP and its active metabolite, MEHP, do not bind to the human androgen receptor (Parks et al., 2000). Some phthalates behave like estrogen receptor ligands in that the phthalates inhibited binding of estrogen to isolated estrogen receptors and induced estrogen-responsive endpoints in vitro (summarized in Moore, 2000
). The relevance of these findings is questioned as monoesters, considered to be the proximate metabolites, were inactive in these in vitro assays and the phthalate diesters that do alter estrogen receptor activity only do so at concentrations that approach solubility of the compound, which could lead to nonspecific effects. Importantly, the phthalates were uniformly negative in a number of in vivo tests for estrogenicity including the uterotrophic assay (Moore, 2000
). Taken together, these studies indicate that phthalates do not mediate their effects through estrogen or androgen receptors, but rather, support PPAR subtypes as primary nuclear receptor targets for phthalate esters.
Correlation of PPAR Activation to Male Reproductive Tract Malformations
The strength of the monoester as a PPAR activator partially correlates with the ability of the parent phthalate to act as a male reproductive toxicant (Table 3). Monomethyl and monoethyl phthalate were either inactive or only weakly active as PPAR activators. The parent phthalates dimethyl and diethyl phthalate were inactive as in utero reproductive toxicants (Gray et al., 2000). In contrast, MEHP was an activator of all three mouse PPAR subtypes and DEHP exposure led to a spectrum of male reproductive tract changes in rats (Gray et al., 2000
; Moore et al., 2001
; Parks et al., 2000
). BBP is hydrolyzed to either monobenzyl phthalate or monobutyl phthalate with the ratio of hydrolysis products in rats being approximately 3:5, respectively (Mikuriya et al., 1988
). Monobenzyl phthalate activated all PPAR subtypes and BBP was positive as a reproductive toxicant (Gray et al., 2000
; Nagao et al., 2000
; Tyl et al., 2004
).
There are two outliers in this comparison. DINP was a very weak reproductive toxicant while MINP was a moderate activator of mouse PPAR and PPAR
(Bility et al., 2004
). DBP is a reproductive toxicant in rats despite the fact that MBP was only weakly active in PPAR transactivation assays (Bility et al., 2004
; Hurst and Waxman, 2003
; Lapinskas et al., 2004
). The weak activity of MBP in PPAR transactivation assays was surprising given that DBP, like DEHP and BBP, acts like a typical PP in the rat liver (Corton et al., 1996
; Marsman, 1995
) and effects in the mouse liver induced by DBP as well as DEHP and DINP are dependent on PPAR
(Anderson et al., 1999
; Lapinskas et al., 2004
; Valles et al., 2003
; Ward et al., 1998
). Although treatment with MBP induced the same effects as DBP in the juvenile rat testis (Foster et al., 1981
; Oishi and Hiraga, 1980
) indicating that MBP is the proximate metabolite, no studies have been carried out in which MBP metabolites were comprehensively examined for toxic effects in the testis as well as abilty to activate PPARs. Candidate metabolites include MBP-glucuronide, a dominant MBP metabolite in adult rats (Foster et al., 1983
; Tanaka et al., 1978
) and omega and omega-1 products of MBP (Tanaka et al., 1978
). It is also possible that a metabolite of DBP or DBP itself activates PPARs indirectly, i.e., by releasing a lipid activator of PPAR as discussed above a process which would not necessarily be detectable using transactivation assays. The fact that two out of six phthalates are outliers in this comparison weakens the hypothesis that PPARs are generally involved in phthalate-induced male reproductive tract defects.
Regulation of Sex Hormone Synthesis and Catabolism Genes by Phthalate Esters
As discussed above, BBP, DBP, and DEHP decrease testosterone levels in the fetus and in the young male rat. Consistent with this, genes involved in testosterone biosynthesis were uniformly down-regulated by DBP exposure in the fetal testis (Barlow et al., 2003; Shultz et al., 2001
; Thompson et al., 2004
) (Fig. 2A). The genes include Scavenger Receptor Class B, type 1 (SR-B1) and steroidogenic acute regulatory protein (StAR) (Barlow et al., 2003
; Shultz et al., 2001
). SR-B1 mediates the selective uptake of cholesterol esters from high-density lipoproteins, and StAR carries cholesterol from the outer to the inner mitochondrial membrane. The peripheral benzodiazepine receptor (PBR), which also carries cholesterol into the mitochondria was down-regulated by WY-14,643 and DEHP in adult mouse testes in a PPAR
-dependent manner (Gazouli et al., 2002
). In the fetal rat testis, PBR mRNA was up-regulated by DBP but by immunohistochemistry the protein was decreased in Leydig cells (Lehmann et al., 2004
). Leydig cell mitochondria isolated from fetuses exposed to DBP in utero, exhibited decreased uptake of cholesterol supporting altered cholesterol handling for the decreases in testosterone synthesis (Thompson et al., 2004
). Other genes involved in steroid biosynthesis that were down-regulated by DBP included P450 side chain cleavage enzyme (P450scc) thought to be the limiting enzymatic step in testosterone biosynthesis, 3ß-hydroxysteroid dehydrogenase (3ß-HSD) and CYP17
(Barlow et al., 2003
; Shultz et al., 2001
). Uniform decreases in the expression of these steroidogenic genes especially in a dose-dependent manner (Lehmann et al., 2004
) is consistent with decreased levels of testicular testosterone.
|
Phthalate esters along with other PP, also alter the expression of testosterone and estrogen metabolism genes (Figs. 2A and 2B). Among these, 5-reductase which converts testosterone to the more potent androgen, dihydrotestosterone was up-regulated in the prepubertal rat testis by DEHP (Kim et al., 2003
). Multiple cytochrome P450 family members which hydroxylate testosterone were altered by PP exposure but in ways that do not clearly indicate a role in decreasing testosterone levels. CYP2C7 and CYP2C11 were down-regulated while CYP3A2 was up-regulated in the male rat liver (Corton et al., 1998
; Fan et al., 2004-a
,b
). CYP2C11 and CYP3A were both up-regulated in the testes (Kim et al., 2003
). WY-14,643 increased expression of fatty acyl-CoA enzyme A:testosterone acyl transferase in the liver (Xu et al., 2001
). The down-regulation of CYP2C11 by a PP required PPAR
; the site within the CYP2C11 promoter required for down-regulation by PP was identified and likely interacts with transcription factors other than PPAR
implying that PPAR
down-regulates CYP2C11 through an indirect mechanism (Ripp et al., 2003
).
Serum estrogen levels were increased in male rats after DEHP exposure (Akingbemi et al., 2004; Eagon et al., 1994
) and after exposure to a number of PP (Biegel et al., 2001
; Liu et al., 1996
). Phthalates alter the expression of many estrogen metabolizing enzymes (Fig. 2B). Aromatase exhibits both up-and down-regulation by PP depending on the tissue and compound (Biegel et al., 2001
; Kim et al., 2003
; Lovekamp and Davis, 2001
; Lovekamp-Swan et al., 2003
; Mu et al., 2001
; Rubin et al., 2000
; Toda et al., 2003
). Genes that decrease estrogen levels were increased after PP exposure including 17ß-hydroxysteroid dehydrogenase, type IV (Corton et al., 1996
) and fatty acyl-CoA enzyme A:estradiol acyl transferase (Xu et al., 2001
). However, these changes may be offset by decreases in the estrogen hydroxylases CYP1B1 after exposure to DBP, DEHP, and BBP in the testis (Seo et al., 2004
) or CYP2C11 (Corton et al., 1998
) and estrogen sulfotransferase (Fan et al., 2004-b
) after WY, GEM, or DBP exposure in rat livers. A handful of these genes involved in testosterone or estrogen metabolism are directly regulated by PPAR
either in the liver or testis as determined by studies in PPAR
-null mice. These include 17ß-HSD, type IV (Corton et al., 1996
) and the CYP3A2 ortholog Cyp3a11 (Fan et al., 2004-b
). These results point to a role for PPAR
in regulating expression of some sex steroid metabolism genes upon phthalate exposure in the adult animal. Although these studies help us appreciate the gene targets of phthalates involved in regulation of steroid metabolism, more work is needed to determine the mechanism by which phthalates alter the expression of these genes, whether these genes are also regulated in parallel at the protein level and the contribution of these collective changes to phthalate toxicity in the postnatal testis.
PPAR and Phthalate-Induced Testicular Toxicity
The role of PPAR in phthalate-induced developmental and testicular toxicity has been determined directly in wild-type and PPAR
-null mice in two studies. In the first study (Peters et al., 1997
), pregnant dams were dosed with DEHP at GD 8 and GD 9 (before development of the male reproductive tract) and malformations of the fetuses were evaluated on GD 10 and GD 18. DEHP exposure decreased crown-rump length and increased the incidence of open neural tubes (failure of the hind- and mid-brain to close) in both DEHP-treated wild-type and PPAR
-null mice compared to controls, demonstrating that DEHP-induced malformations are PPAR
-independent. However, this study cannot be used to determine the role for PPAR
in phthalate-induced male reproductive tract defects from in utero exposure, because DEHP treatment did not occur during the critical window of development of the male reproductive tract and to our knowledge, the rat model of in utero male reproductive tract defects has not been successfully recapitulated in mice.
In the second study (Ward et al., 1998), male wild-type and PPAR
-null mice were fed a diet containing 12,000 ppm DEHP and lesions in the liver and testis were examined. In the liver all of the expected effects of DEHP were dependent on PPAR
. After four and eight weeks of exposure, testis from wild-type mice exhibited mild or moderate toxic effects including focal tubular degenerative lesions, decreased spermatogenesis, and giant cells within the epididymis. In sharp contrast, the testis from PPAR
-null mice at these time points were predominantly normal except for a few tubules that lacked normal indicators of spermatogenesis. PPAR
-null mice at 24 weeks exhibited moderate testicular effects. However, all of the wild-type mice were sacrificed at 1216 weeks due to toxicity when there was severe testicular atrophy making it impossible to directly compare the effects in the two strains at the 24 week time point. The authors concluded that DEHP effects in the testis were the result of both PPAR
-dependent and -independent mechanisms. This study indicates that PPAR
determines the timing and severity of testicular toxicity by DEHP. To better characterize the role of PPAR
in phthalate-induced testicular toxicity, additional studies using other phthalates should be carried out in wild-type and PPAR
-null mice. Given that PPARß is expressed in the testis, PPARß-null mice could also be used to determine any role played by this receptor in phthalate-induced testicular toxicity. Determining a role for PPAR
will require construction of testis-specific nullizygous mice as the PPAR
-null mutation is embryonically lethal (Barak et al., 1999
).
Cross-Talk between PPAR and Nuclear Receptor Signaling: Potential Impact on the Male Reproductive Tract
Several studies have demonstrated cross-talk between PPAR and other nuclear receptors. Cross-talk occurs when signaling pathways other than the primary pathway are activated or repressed through interactions with components of the primary pathway. PPAR-induced interference of other nuclear receptor pathways occurs through competition between PPARs and other receptors for binding to (1) the same DNA response element or (2) a common heterodimerization partner (Fig. 3). In the Supplementary Materials we examine cross-talk between PPARs and nuclear receptors for estrogen, thyroid hormone, and retinoic acid that play roles in the development or homeostasis of the testis. Many of these studies supporting interactions between PPAR and other nuclear receptors were either performed with PP other than phthalates in in vitro cell models allowing only conjecture as to how PPAR-phthalate interactions may disrupt male reproductive tract function in vivo. Further work is needed before these proposed mechanisms should be considered to play a role in phthalate-induced effects in the male reproductive tract.
|
Other evidence exists to argue for little, if any participation of PPARs in phthalate-induced testicular effects. Although phthalates and PP can activate PPARs, only the phthalates are generally considered testicular toxicants. However, it is not unprecedented that structurally distinct classes of nuclear receptor ligands (e.g., ER ligands) have unique properties as agonists, partial agonists, or antagonists depending on receptor-ligand conformations and subsequent interactions with tissue-specific co-activators/co-repressors (McDonnell et al., 2002). With this in mind, it is interesting to note that many genes normally up-regulated by PP in the adult rat liver were down-regulated by DBP in the fetal testis and include those that are known targets of PPAR
including fatty acid ßoxidation genes (Shultz et al., 2001
). Phthalate effects in the adult testis can occur rapidly (within 2 h), likely before any phenotypic effects of PPAR-mediated gene regulation would be observed. Two phthalates, DBP and DINP, do not neatly fit into a relationship of inducing male reproductive tract malformations while the corresponding monoester induces PPAR activation. DBP is a strong male reproductive toxicant but MBP only weakly activates PPARs; DINP is a weak toxicant but MINP is a moderately strong PPAR activator. The fact that phthalate-induced testicular toxicity occurs in species that do not respond to PP-induced liver effects has been used to invoke a PPAR
-independent mechanism, but comprehensive information on PPAR
expression in the testis of responsive vs. nonresponsive species is lacking.
One way to rationalize these seemingly disparate findings is to invoke a mechanism that at least in the neonatal testis, includes both PPAR-dependent and -independent events leading to testicular toxicity after phthalate exposure. Future investigations should be designed to directly determine the role of PPARs as potential mediators of phthalate effects. Resolving a role for PPARs will be expedited by a comprehensive determination of PPAR expression in the developing testis and testing the effects of multiple phthalates in established mouse models nullizygous for each PPAR gene during male reproductive tract development.
![]() |
SUPPLEMENTARY DATA |
---|
![]() ![]() ![]() ![]() ![]() |
---|
![]() |
ACKNOWLEDGMENTS |
---|
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() |
---|
Akingbemi, B. T., Ge, R., Klinefelter, G. R., Zirkin, B. R., and Hardy, M. P. (2004). Phthalate-induced Leydig cell hyperplasia is associated with multiple endocrine disturbances. Proc. Natl. Acad. Sci. U.S.A. 101, 775780.
Albro, P. W., and Moore, B. (1974). Identification of the metabolites of simple phthalate diesters in rat urine. J. Chromatogr. 94, 209218.[CrossRef][Medline]
Anderson, S. P., Cattley, R. C., and Corton, J. C. (1999). Hepatic expression of acute-phase protein genes during carcinogenesis induced by peroxisome proliferators. Mol. Carcinog. 26, 226238.[CrossRef][ISI][Medline]
Barlow, N. J., and Foster, P. M. (2003). Pathogenesis of male reproductive tract lesions from gestation through adulthood following in utero exposure to di(n-butyl) phthalate. Toxicol. Pathol. 31, 397410.[CrossRef][ISI][Medline]
Barlow, N. J., McIntyre, B. S., and Foster, P. M. (2004). Male reproductive tract lesions at 6, 12, and 18 months of age following in utero exposure to di(n-butyl) phthalate. Toxicol. Pathol. 32, 7990.[CrossRef][ISI][Medline]
Barlow, N. J., Phillips, S. L., Wallace, D. G., Sar, M., Gaido, K. W., and Foster, P. M. (2003). Quantitative changes in gene expression in fetal rat testes following exposure to di(n-butyl) phthalate. Toxicol. Sci. 73, 431441.
Barak, Y., Nelson, M. C., Ong, E. S., Jones, Y. Z., Ruiz-Lozano, P., Chien, K. R., Koder, A., and Evans, R. M. (1999). PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell. 4, 585595.[ISI][Medline]
Bars, R. G., Bell, D. R., and Elcombe, C. R. (1993). Induction of cytochrome P450 and peroxisomal enzymes by clofibric acid in vivo and in vitro. Biochem. Pharmacol. 45, 20452053.[CrossRef][ISI][Medline]
Bergstrom, R., Adami, H. O., Mohner, M., Zatonski, W., Storm, H., Ekbom, A., Tretli, S., Teppo, L., Akre, O., and Hakulinen, T. (1996). Increase in testicular cancer incidence in six European countries: A birth cohort phenomenon. J. Natl. Cancer Inst. 88, 727733.
Biegel, L. B., Hurtt, M. E., Frame, S. R., Applegate, M., O'Connor, J. C., and Cook, J. C. (1992). Comparison of the effects of Wyeth-14,643 in Crl:CD BR and Fisher-344 rats. Fundam. Appl. Toxicol. 9, 590597.
Biegel, L. B., Liu, R. C., Hurtt, M. E., and Cook, J. C. (1995). Effects of ammonium perfluorooctanoate on Leydig cell function: in vivo, in vitro, and ex vivo studies. Toxicol. Appl. Pharmacol. 134, 1825.[CrossRef][ISI][Medline]
Biegel, L. B., Hurtt, M. E., Frame, S. R., O'Connor, J. C., and Cook, J. C. (2001) Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicol. Sci. 60, 4455.
Bility, M. T., Thompson, J. T., McKee, R. H., David, R. M., Butala, J. H., Vanden Heuvel, J. P., and Peters, J. M. (2004). Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters. Toxicol. Sci. 82, 170182.
Braissant, O., and Wahli, W. (1998). Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development. Endocrinology 139, 27482754.
Cook, J. C., Murray, S. M., Frame, S. R., and Hurtt, M. E. (1992). Induction of Leydig cell adenomas by ammonium perfluorooctanoate: A possible endocrine-related mechanism. Toxicol. Appl. Pharmacol. 113, 209217.[CrossRef][ISI][Medline]
Corton, J. C., Anderson, S. P., and Stauber, A. (2000). Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu. Rev. Pharmacol. Toxicol. 40, 491518.[CrossRef][ISI][Medline]
Corton, J. C., Bocos, C., Moreno, E. S., Merritt, A., Marsman, D. S., Sausen, P. J., Cattley, R. C., and Gustafsson, J. A. (1996). Rat 17 beta-hydroxysteroid dehydrogenase type IV is a novel peroxisome proliferator-inducible gene. Mol. Pharmacol. 50, 11571166.[Abstract]
Corton, J. C., Fan, L. Q., Brown, S., Anderson, S. P., Bocos, C., Cattley, R. C., Mode, A., and Gustafsson, J. A. (1998). Down-regulation of cytochrome P450 2C family members and positive acute-phase response gene expression by peroxisome proliferators chemicals. Mol. Pharmacol. 54, 463473.
Dostal, L. A., Chapin, R. E., Stefanski, S. A., Harris, M. W., and Schwetz, B. A. (1988). Testicular toxicity and reduced Sertoli cell numbers in neonatal rats by di(2-ethylhexyl)phthalate and the recovery of fertility as adults. Toxicol. Appl. Pharmacol. 95, 104121.[ISI][Medline]
Eagon, P. K., Chandar, N., Epley, M. J., Elm, M. S., Brady, E. P., and Rao, K. N. (1994). Di(2-ethylhexyl)phthalate-induced changes in liver estrogen metabolism and hyperplasia. Int. J. Cancer 58, 736743.[ISI][Medline]
Elbrecht, A., Chen, Y., Cullinan, C. A., Hayes, N., Leibowitz, M., Moller, D. E., and Berger, J. (1996). Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem. Biophys. Res. Commun. 224, 431437.[CrossRef][ISI][Medline]
Ema, M., Miyawaki, E., and Kawashima, K. (2000). Critical period for adverse effects on development of reproductive system in male offspring of rats given di-n-butyl phthalate during late pregnancy. Toxicology Lett. 111, 271278.[CrossRef][ISI][Medline]
Ema, M., and Miyawaki, E. (2002). Effects on development of the reproductive system in male offspring of rats given butyl benzyl phthalate during late pregnancy. Reprod. Toxicol. 16, 7176.[CrossRef][ISI][Medline]
Emmen, J.M., McLusky, A., Adham, I.M., Engel, W., Verhoef-Post, M., Themmen, A.P., Grootegoed, J.A., and Brinkman, A. O. (2000). Involvement of insulin-like factor 3 (Insl3) in diethylstilbestrol-induced cryptorchidism. Endocrinology, 141, 846849.
Fan, L.-Q., Brown-Borg, H., Brown, S., Westin, S., Mode, A., and Corton, J. C. (2004-a). PPAR activators down-regulate CYP2C7, a retinoic acid and testosterone hydroxylase. Toxicology., 203, 4148.[CrossRef][ISI][Medline]
Fan, L.-Q., You, L., Brown-Borg, H., Brown, S., Edwards, R. J., and Corton, J. C. (2004-b). Regulation of phase I and phase II steroid metabolism enzymes by PPAR activators. Toxicology., 204, 109121.[CrossRef][ISI][Medline]
Fisher, J. S., Macpherson, S., Marchetti, N., and Sharpe, R. M. (2003). Human testicular dysgenesis syndrome: A possible model using in-utero exposure of the rat to dibutyl phthalate. Hum. Reprod. 18, 13831394.
Foster, P. M., Cook, M. W., Thomas, L. V., Walters, D. G., and Gangolli, S. D. (1983). Differences in urinary metabolic profile from di-n-butyl phthalate-treated rats and hamsters. A possible explanation for species differences in susceptibility to testicular atrophy. Drug Metab. Dispos. 11, 5961.[Abstract]
Foster, P. M., Lake, B. G., Thomas, L. V., Cook, M. W., and Gangolli, S. D. (1981). Studies on the testicular effects and zinc excretion produced by various isomers of monobutyl-o-phthalate in the rat. Chem. Biol. Interact. 34, 233238.[CrossRef][ISI][Medline]
Foster, P. M., Mylchreest, E., Gaido, K. W., and Sar, M. (2001). Effects of phthalate esters on the developing reproductive tract of male rats. Hum. Reprod. Update 7, 231235.
Fu, T., Kozarsky, K. F., and Borensztajn, J. (2003). Overexpression of SR-BI by adenoviral vector reverses the fibrate induced hypercholesterolemia of apolipoprotein E-deficient mice. J. Biol. Chem. 278, 5255952563.
Gangolli, S. D. (1982). Testicular effects of phthalate esters. Environ. Health Perspect. 45, 7784.[ISI][Medline]
Gazouli, M., Yao, Z. X., Boujrad, N., Corton, J. C., Culty, M., and Papadopoulos, V. (2002). Effect of peroxisome proliferators on Leydig cell peripheral-type benzodiazepine receptor gene expression, hormone-stimulated cholesterol transport, and steroidogenesis: Role of the peroxisome proliferator-activator receptor alpha. Endocrinology 143, 25712583.
Giammona, C. J., Sawhney, P., Chandrasekaran, Y., and Richburg, J. H. (2002). Death receptor response in rodent testis after mono-(2-ethylhexyl) phthalate exposure. Toxicol. Appl. Pharmacol. 185, 119127.[CrossRef][ISI][Medline]
Gray, T. J., Rowland, I. R., Foster, P. M., and Gangolli, S. D. (1982). Species differences in the testicular toxicity of phthalate esters. Toxicol Lett. 11, 141147.[CrossRef][ISI][Medline]
Gray, L. E., Jr., Wolf, C., Lambright, C., Mann, P., Price, M., Cooper, R. L., and Ostby, J. (1999). Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinae, p,p'-DDE, and ketoconazole) and toxic substances (dibutyl- and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differential produces diverse profiles of reproductive malformations in the male rat. Toxicol. Ind. Health 15, 94118.[ISI][Medline]
Gray, L. E., Jr., Ostby, J., Furr, J., Price, M., Veeramachaneni, D. N., and Parks, L. (2000). Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicol. Sci. 58, 350365.
Gray, T. J., and Gangolli, S. D. (1986). Aspects of the testicular toxicity of phthalate esters. Environ. Health Perspect. 65, 229235.[ISI][Medline]
Gu, S., Ripp, S. L., Prough, R. A., and Geoghegan, T. E. (2003). Dehydroepiandrosterone affects the expression of multiple genes in rat liver including 11 beta-hydroxysteroid dehydrogenase type 1: A cDNA array analysis. Mol. Pharmacol. 63, 722731.
Hase, T., Yoshimura, R., Mitsuhashi, M., Segawa, Y., Kawahito, Y., Wada, S., Nakatani, T., and Sano, H. (2002). Expression of peroxisome proliferator-activated receptors in human testicular cancer and growth inhibition by its agonists. Urology 60, 542547.[CrossRef][ISI][Medline]
Heindel, J. J., and Chapin, R. E. (1989). Inhibition of FSH-stimulated cAMP accumulation by mono(2-ethylhexyl) phthalate in primary rat Sertoli cell cultures. Toxicol Appl Pharmacol. 97, 377385.[CrossRef][ISI][Medline]
Heindel, J. J., and Powell, C. J. (1992). Phthalate ester effects on rat Sertoli cell function in vitro: Effects of phthalate side chain and age of animal. Toxicol. Appl. Pharmacol. 115, 116123.[CrossRef][ISI][Medline]
Higuchi, T. T., Palmer, J. S., Gray, L. E., Jr., and Veeramachaneni, D. N. (2003). Effects of dibutyl phthalate in male rabbits following in utero, adolescent, or postpubertal exposure. Toxicol. Sci. 72, 301313.
Hurst, C. H., and Waxman, D. J. (2003). Activation of PPARalpha and PPARgamma by environmental phthalate monoesters. Toxicol. Sci. 74, 297308.
Ichimura, T., Kawamura, M., and Mitani, A. (2003). Co-localized expression of FasL, Fas, Caspase-3 and apoptotic DNA fragmentation in mouse testis after oral exposure to di(2-ethylhexyl)phthalate. Toxicology 194, 3542.[CrossRef][ISI][Medline]
Imajima, T., Shono, T., Kai, H., Zakaria, O., and Suita, S. (2001). The biological effect of phthalate esters on transabdominal migration of the testis in fetal rats in comparison with the antiandrogen flutamide. Pediatr. Surg. Int. 17, 164166.[CrossRef][ISI][Medline]
Jones, H. B., Garside, D. A., Liu, R., and Roberts, J. C. (1993). The influence of phthalate esters on Leydig cell structure and function in vitro and in vivo. Exp. Mol. Pathol. 58, 179193.[CrossRef][ISI][Medline]
Kasahara, E., Sato, E. F., Miyoshi, M., Konaka, R., Hiramoto, K., Sasaki, J., Tokuda, M., Nakano, Y., and Inoue, M. (2002). Role of oxidative stress in germ cell apoptosis induced by di(2-ethylhexyl)phthalate. Biochem. J. 365, 849856.[ISI][Medline]
Kim, H. S., Saito, K., Ishizuka, M., Kazusaka, A., and Fujita, S. (2003). Short period exposure to di-(2-ethylhexyl) phthalate regulates testosterone metabolism in testis of prepubertal rats. Arch. Toxicol. 77, 446451.[CrossRef][ISI][Medline]
Klaunig, J. E., Babich, M. A., Baetcke, K. P., Cook, J. C., Corton, J. C., David, R. M., DeLuca, J. G., Lai, D. Y., McKee, R. H., Peters, J. M., Roberts, R. A., and Fenner-Crisp, P. A. (2003). PPARalpha agonist-induced rodent tumors: modes of action and human relevance. Crit. Rev. Toxicol. 33, 655780.[ISI][Medline]
Lake, B. G., Brantom, P. G., Gangolli, S. D., Butterworth, K. R., and Grasso, P. (1976). Studies on the effects of orally administered Di-(2-ethylhexyl) phthalate in the ferret. Toxicology 6, 341356.[CrossRef][ISI][Medline]
Lampen, A., Zimnik, S., and Nau, H. (2003). Teratogenic phthalate esters and metabolites activate the nuclear receptors PPARs and induce differentiation of F9 cells. Toxicol. Appl. Pharmacol. 188, 1423.[CrossRef][ISI][Medline]
Lapinskas, P. J., Brown, S., Leesnitzer, L. M., Blanchard, S., Swanson, C., Cattley, R. C., and Corton, J. C. (2004). Role of PPAR in mediating the effects of phthalates and metabolites in the liver. Toxicology. In press.
Lee, S. S., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., and Gonzalez, F. J. (1995). Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell Biol. 15, 30123022.[Abstract]
Lehmann, K. P., Phillips, S., Sar, M., Foster, P. M., and Gaido, K. W. (2004). Dose-dependent alterations in gene expression and testosterone synthesis in the fetal testes of male rats exposed to di (n-butyl) phthalate. Toxicol. Sci., 81, 6068.
Lemberger, T., Desvergne, B., and Wahli, W. (1996). Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology. Annu. Rev. Cell Dev. Biol. 12, 335363.[CrossRef][ISI][Medline]
Li, H., and Kim, K. H. (2003) Effects of mono-(2-ethylhexyl) phthalate on fetal and neonatal rat testis organ cultures. Biol. Reprod. 69, 19641972.
Li, L. H., Jester, W. F., Jr., and Orth, J. M. (1998). Effects of relatively low levels of mono-(2-ethylhexyl) phthalate on cocultured Sertoli cells and gonocytes from neonatal rats. Toxicol. Appl. Pharmacol. 153, 258265.[CrossRef][ISI][Medline]
Li, L. H., Jester, W. F., Jr., Laslett, A. L., and Orth, J. M. (2000). A single dose of di-(2-ethylhexyl) phthalate in neonatal rats alters gonocytes, reduces Sertoli cell proliferation, and decreases cyclin D2 expression. Toxicol. Appl. Pharmacol. 166, 222229.[CrossRef][ISI][Medline]
Liu, R. C., Hahn, C., and Hurtt, M. E. (1996). The direct effect of hepatic peroxisome proliferators on rat Leydig cell function in vitro. Fundam. Appl. Toxicol. 30, 102108.[CrossRef][ISI][Medline]
Lloyd, S. C., and Foster, P. M. (1988). Effect of mono-(2-ethylhexyl)phthalate on follicle-stimulating hormone responsiveness of cultured rat Sertoli cells. Toxicol. Appl. Pharmacol. 95, 484489.[CrossRef][ISI][Medline]
Lock, E. A., Mitchell, A. M., and Elcombe, C. R. (1989). Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu. Rev. Pharmacol. Toxicol. 29, 145163.[CrossRef][ISI][Medline]
Lovekamp, T. N., and Davis, B. J. (2001). Mono-(2-ethylhexyl) phthalate suppresses aromatase transcript levels and estradiol production in cultured rat granulosa cells. Toxicol. Appl. Pharmacol. 172, 217224.[CrossRef][ISI][Medline]
Lovekamp-Swan, T., Jetten, A. M., and Davis, B. J. (2003). Dual activation of PPARalpha and PPARgamma by mono-(2-ethylhexyl) phthalate in rat ovarian granulosa cells. Mol. Cell Endocrinol. 201, 133141.[CrossRef][ISI][Medline]
Luebker, D. J., Hansen, K. J., Bass, N. M., Butenhoff, J. L., and Seacat, A. M. (2002). Interactions of fluorochemicals with rat liver fatty acid-binding protein. Toxicology 176, 175185.[CrossRef][ISI][Medline]
Malerod, L., Sporstol, M., Juvet, L. K., Mousavi, A., Gjoen, T., and Berg, T. (2003). Hepatic scavenger receptor class B, type I is stimulated by peroxisome proliferator-activated receptor gamma and hepatocyte nuclear factor 4alpha. Biochem. Biophys. Res. Commun. 305, 557565.[CrossRef][ISI][Medline]
Maloney, E. K., and Waxman, D. J. (1999). trans-Activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals. Toxicol. Appl. Pharmacol. 161, 209218.[CrossRef][ISI][Medline]
Mardones, P., Pilon, A., Bouly, M., Duran, D., Nishimoto, T., Arai, H., Kozarsky, K. F., Altayo, M., Miquel, J. F., Luc, G., Clavey, V., Staels, B., and Rigotti, A. (2003). Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice. J. Biol. Chem. 278, 78847890.
Marsman, D. (1995). NTP technical report on the toxicity studies of dibutyl phthalate (CAS No. 84-74-2) administered in feed to F344/N rats and B6C3F1 mice. Toxic Rep. Ser. 30, 1G5.[Medline]
McDonnell, D. P., Connor, C. E., Wijayaratne, A., Chang, C. Y., and Norris, J. D. (2002). Definition of the molecular and cellular mechanisms underlying the tissue-selective agonist/antagonist activities of selective estrogen receptor modulators. Recent Prog. Horm. Res. 57, 295316.
Mikuriya, H., Ikemoto, I., and Tanaken, A., (1988). Urinary metabolites contributing to the testicular damage induced by butylbenzyl phthalate. Jikeikai Med. J. 35, 403.
Moore, N. P. (2000). The oestrogenic potential of the phthalate esters. Reprod. Toxicol. 14, 183192.[CrossRef][ISI][Medline]
Moore, R. W., Rudy, T. A., Lin, T. M., Ko, K., and Peterson, R. E. (2001). Abnormalities of sexual development in male rats with in utero and lactational exposure to the antiandrogenic plasticizer di(2-ethylhexyl) phthalate. Environ. Health Perspect. 109, 229237.[ISI][Medline]
Mu, Y. M., Yanase, T., Nishi, Y., Takayanagi, R., Goto, K., and Nawata, H. (2001). Combined treatment with specific ligands for PPARgamma:RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells. Mol. Cell Endocrinol. 181, 239248.[CrossRef][ISI][Medline]
Mylchreest, E., Sar, M., Cattley, R. C., and Foster, P. M. (1999). Disruption of androgen-regulated male reproductive development by di(n-butyl) phthalate during late gestation in rats is different from flutamide. Toxicol. Appl. Pharmacol. 156, 8195.[CrossRef][ISI][Medline]
Mylchreest, E., Sar, M., Wallace, D. G., and Foster, P. M. (2002). Fetal testosterone insufficiency and abnormal proliferation of Leydig cells and gonocytes in rats exposed to di(n-butyl) phthalate. Reprod. Toxicol. 16, 1928.[CrossRef][ISI][Medline]
Mylchreest, E., Wallace, D. G., Cattley, R. C., and Foster, P. M. (2000). Dose-dependent alteratons in androgen-regulated male reproductive development in rats exposed to di(n-butyl) phthalate during late gestation. Toxicol. Sci. 55, 143151.
Nagao, T., Ohta, R., Marumo, H., Shindo, T., Yoshimura, S., and Ono, H. (2000). Effect of butyl benzyl phthalate in Sprague-Dawley rats after gavage administration: A two-generation reproductive study. Reprod. Toxicol. 14, 513532.[CrossRef][ISI][Medline]
Nemali, M. R., Usuda, N., Reddy, M. K., Oyasu, K., Hashimoto, T., Osumi, T., Ra, M. S., and Reddy, J. K. (1988). Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat. Cancer Res. 48, 53165324.[Abstract]
Nichols, J. S., Parks, D. J., Consler, T. G., and Blanchard, S. G. (1998). Development of a scintillation proximity assay for peroxisome proliferator-activated receptor gamma ligand binding domain. Anal. Biochem. 257, 112119.[CrossRef][ISI][Medline]
Ohtani, H., Miura, I., and Ichikawa, Y. (2000). Effects of dibutyl phthalate as an environmental endocrine disruptor on gonadal sex differentiation of genetic males of the frog Rana rugosa. Environ. Health Perspect. 108, 11891193.[ISI][Medline]
Oishi, S., and Hiraga, K. (1980). Testicular atrophy induced by phthalic acid monoesters: Effects of zinc and testosteronne concentrations. Toxicology 15, 197202.[CrossRef][ISI][Medline]
Parks, L. G., Ostby, J. S., Lambright, C. R., Abbott, B. D., Klinefelter, G. R., Barlow, N. J., and Gray, L. E., Jr. (2000). The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicol. Sci. 58, 339349.
Parvinen, M. (1982). Regulation of the seminiferous epithelium. Endocr. Rev. 3, 404417.[ISI][Medline]
Peters, J. M., Lee, S. S., Li, W., Ward, J. M., Gavrilova, O., Everett, C., Retiman, M. L., Hudson, L. D., and Gonzalez, F. J. (2000). Growth, adipose, brain, and skin alterations resulting from tageted disruption of the mouse peroxisome proliferator-activated reeceptor beta (delta). Mol. Cell Biol. 20, 51195128.
Peters, J. M., Taubeneck, M. W., Keen, C. L., and Gonzalez, F. J. (1997). Di(2-ethylhexyl) phthalate induces a functional zinc deficiency during pregnancy and teratogenesis that is independent of peroxisome proliferator-activated receptor-alpha. Teratology 56, 311316.[CrossRef][ISI][Medline]
Piersma, A. H., Verhoef, A., te Biesebeek, J. D., Pieters, M. N., and Slob, W. (2000). Developmental toxicity of butyl benzyl phthalate in the rat using a multiple dose study design. Reprod. Toxicol. 14, 417425.[CrossRef][ISI][Medline]
Richburg, J. H., and Boekelheide, K. (1996). Mono-(2-ethylhexyl) phthalate rapidly alters both Sertoli cell vimentin filaments and germ cell apoptosis in young rat testes. Toxicol. Appl. Pharmacol. 137, 4250.[CrossRef][ISI][Medline]
Richburg, J. H., Johnson, K. J., Schoenfeld, H. A., Meistrich, M. L., and Dix, D. J. (2002). Defining the cellular and molecular mechanisms of toxicant action in the testis. Toxicol. Lett. 135, 167183.[CrossRef][ISI][Medline]
Richburg, J. H., Nanez, A., Williams, L. R., Embree, M. E., and Boekelheide, K. (2000). Sensitivity of testicular germ cells to toxicant-induced apoptosis in gld mice that express a nonfunctional form of Fas ligand. Endocrinology 141, 787793.
Richert, L., Lamboley, C., Viollon-Abadie, C., Grass, P., Hartmann, N., Laurent, S., Heyd, B., Mantion, G., Chibout, S. D., and Staedtler, F. (2003). Effects of clofibric acid on mRNA expression profiles in primary cultures of rat, mouse and human hepatocytes. Toxicol. Appl. Pharmacol. 191, 130146.[CrossRef][ISI][Medline]
Ripp, S. L., Falkner, K. C., Pendleton, M. L., Tamasi, V., and Prough, R. A. (2003). Regulation of CYP2C11 by dehydroepiandrosterone and peroxisome proliferators: Identification of the negative regulatory region of the gene. Mol Pharmacol. 64, 113122.
Rubin, G. L., Zhao, Y., Kalus, A. M., and Simpson, E. R. (2000). Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: Possible implications for breast cancer therapy. Cancer Res. 60, 16041608.
Schultz, R., Yan, W., Toppari, J., Volkl, A., Gustafsson, J. A., and Pelto-Huikko, M. (1999). Expression of peroxisome prolierator-activated receptor alpha messenger ribonucleic acid and protein in human and rat testis. Endocrinology 140, 29682975.
Seo, K. W., Kim, K. B., Kim, Y. J., Choi, J. Y., Lee, K. T., and Choi, K. S. (2004). Comparison of oxidative stress and changes of xenobiotic metabolizing enzymes induced by phthalates in rats. Food Chem. Toxicol. 42, 107114.[CrossRef][ISI][Medline]
Sharpe, R. M. (2001). Hormones and testis development and the possible adverse effects of environmental chemicals. Toxicol. Lett. 120, 221232.[CrossRef][ISI][Medline]
Shono, T., and Suita, S. (2003). Dose-dependent effect of phthalate ester on testicular descent in pre- and post natal rats. Urol. Res. 31, 293296.[CrossRef][ISI][Medline]
Shultz, V. D., Phillips, S., Sar, M., Foster, P. M., and Gaido, K. W. (2001). Altered gene profiles in fetal rat testes after in utero exposure to di(n-butyl) phthalate. Toxicol. Sci. 64, 233242.
Skakkebaek, N., Rajpert-De Meyts, and Main, K. (2001). Testicular dysgenesis syndrome: An increasingly common developmental disorder with environmental aspects. Hum. Reprod. 16, 972978.
Staples, C., Peterson, D., Parkerton, T., and Adams, W. (1997). The environmental fate of phthalate esters: A literature review. Chemosphere 35, 667749.[CrossRef][ISI]
Suominen, J. S., Linderborg, J., Nikula, H., Hakovirta, H., Parvinen, M., and Toppari, J. (2003). The effects of mono-2-ethylhexyl phthalate, adriamycin and N-ethyl-N-nitrosourea on stage-specific apoptosis and DNA synthesis in the mouse spermatogenesis. Toxicol. Lett. 143, 163173.[CrossRef][ISI][Medline]
Tanaka, A., Matsumoto, A., and Yamaha, T. (1978). Biochemical studies on phthalic esters. III. Metabolism of dibutyl phthalate (DBP) in animals. Toxicology 9, 109123.[CrossRef][ISI][Medline]
Thompson, C. J., Ross, S. M., and Gaido, K. W. (2004). Di(n-butyl) phthalate impairs cholesterol transport and steroidogenesis in the fetal rat testis through a rapid and reversible mechanism. Endocrinology 145, 12271237.
Toda, K., Okada, T., Miyaura, C., and Saibara, T. (2003). Fenofibrate, a ligand for PPARalpha, inhibits aromatase cytochrome P450 expression in the ovary of mouse. J. Lipid Res. 44, 265270.
Toppari, J., Larsen, J. C., Christiansen, P., Giwecman, P., Guillette, L. J. Jr., Jegou, B., Jensen, T. K., Jouannet, P., Keiding, N., Leffers, H., McLachlan, J. A., Meyer, O., Muller, J., Rajpert-De Meyts, E., Scheike, T., Sharpe, R., Sumpter, J., and Skakkerbaek, N. E. (1996). Male reproductive health and environmental xenoestrogens. Environ. Health Prespect., 104, Suppl 4: 741803.
Tyl, R., Myers, M., Marr, M., Fail, P., Seely, J. Brine, D., Barter, R. A., and Butala, J. H. (2004). Reproductive toxicity evaluation of dietary butyl benzyl phthalate in rats. Reprod. Toxicol. 18, 241264.[CrossRef][ISI][Medline]
Val, P., Lefrancois-Martinez, A. M., Veyssiere, G., and Martinez, A. (2003). SF-1 a key player in the development and differentiation of steroidogenic tissues. Nucl. Recept. 1, 8.[CrossRef][Medline]
Valles, E. G., Laughter, A. R., Dunn, C. S., Cannelle, S., Swanson, C. L., Cattley, R. C., and Corton, J. C. (2003). Role of the peroxisome proliferator-activated receptor alpha in responses to diisononyl phthalate. Toxicology 191, 211225.[CrossRef][ISI][Medline]
Ward, J. M., Peters, J. M., Perella, C. M., and Gonzalez, F. J. (1998). Receptor and nonreceptor-mediated organ-specific toxicity of di-(2-ethylhexyl)phthalate (DEHP) in peroxisome proliferator-activated receptor alpha-null mice. Toxicol. Pathol. 26, 240246.[ISI][Medline]
Wilson, V. S., Lambright, C., Furr, J., Ostby, J., Wood, C., Held, G., and Gray, L. E. (2004). Phthalate ester-induced gubernacular lesions are associated with reduced insl3 gene expression in the fetal rat testis. Toxicol. Lett. 146, 207215.[CrossRef][ISI][Medline]
Wine, R. N., Li, L. H., Barnes, L. H., Gulati, D. K., and Chapin, R. E. (1997). Reproductive toxicity of di-n-butylphthalate in a continuous breeding protocol in Sprague-Dawley rats. Environ. Health Perspect. 105, 102107.[ISI][Medline]
Wong, J. S., and Gill, S. S. (2002). Gene expression changes induced in mouse liver by di(2-ethylhexyl) phthalate. Toxicol. Appl. Pharmacol. 185, 180196.[CrossRef][ISI][Medline]
Xing, G., Zhang, L., Zhang, L., Heynen, T., Yoshikawa, T., Smith, M., Weiss, S., and Detera-Wadleigh, S. (1995). Rat PPAR delta contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei. Biochem. Biophys. Res. Commun. 217, 10151025.[CrossRef][ISI][Medline]
Xu, H. E., Lambert, M. H., Montana, V. G., Parks, D. J., Blanchard, S. G., Brown, P. J., Sternbach, D. D., Lehmann, J. M., Wisely, G. B., Willson, T. M., Kliewer, S. A., and Milburn, M. V. (1999). Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol. Cell. 3, 397403.[ISI][Medline]
Xu, S., Zhu, B. T., Turan, V., Rusyn, I., Thurman, R., Peters, J. M., Gonzalez, F. J., and Conney, A. H. (2001). PPARalpha-dependent induction of liver microsomal esterification of estradiol and testosterone by a prototypical peroxisome proliferator. Endocrinology 142, 35543557.